Peer Review History

Original SubmissionJune 18, 2020
Decision Letter - Vanessa Carels, Editor

PONE-D-20-18677

The inevitability of Covid-19 related distress among healthcare workers: findings from a low caseload country under lockdown

PLOS ONE

Dear Dr. Hawari,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The manuscript has been evaluated by two reviewers, and their comments are available below.

The reviewers have raised a number of concerns that need attention, and they request additiona information on methodological aspects of the study including the reported measures as well as revisions to the statistical analyses.

Could you please revise the manuscript to carefully address the concerns raised?

Please submit your revised manuscript by Feb 25 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  •  
    A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  •  
    A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  •  
    An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Vanessa Carels

Staff Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

 

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please improving statistical reporting and refer to p-values as "p<.001" instead of "p=.000". Our statistical reporting guidelines are available at " ext-link-type="uri" xlink:type="simple">https://journals.plos.org/plosone/s/submission-guidelines#loc-statistical-reporting"

3. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

 

In your revised cover letter, please address the following prompts:

 

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

 

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

 

We will update your Data Availability statement on your behalf to reflect the information you provide.

 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The present study aimed at investigating psychological distress and associated factors in a sample of 1006 Jordanian healthcare workers during a stringent lockdown due to COVID-19 pandemic. Results showed 32% of subjects reporting high distress levels and 20% of subjects suffering very severe distress. Further, around a third and a quarter also reported moderate to severe anxiety and depressive symptoms, respectively, besides another third reporting sleep problems. Authors also reported demographic and other personal characteristics associated to higher distress levels. Particularly, younger age, being female, being pharmacist, working in a cancer hospital, higher workload, suffering burnout or sleep problems, feeling frightened by the virus spreading uncontrollably and by the separation from family and friends were the strongest predictors of higher distress levels.

The topic is timely and well structured. However, some considerations that would help to increase the quality of the work could be taken into account.

Comments:

1) The paper definitely needs the revision of a qualified English native speaker.

2) Authors should provide details on the validity and reliability of each instrument used in the present study. Authors stated that they used only few items of PROMIS questionnaires to assess sleep related impairment and fatigue. The lack of a specific and complete questionnaire to assess these symptoms could represent a limitation when interpreting the present results and should be declared. Further, it could be useful to report which items of these questionnaires were used to the present assessment, describing them in the Methods section.

3) Moreover, burnout was evaluated by a single-item measure, referring to Dolan et al. study (2015). Firstly, the item and its score should be described in Methods. Secondly, the use of a single-item measure could represent another possible limitation in the quality of burnout symptoms assessment, as reported also by Dolan et al. (2015) in their study, and this should be declared in limitations.

4) The paper is interesting because reported data on healthcare workers in a country with low caseloads, confirming the potentially traumatic impact of COVID-19 pandemic on mental health of such population. These data seem to be in line with a recent study assessing burnout, anxiety and depressive symptoms and their association in healthcare workers facing the first phase of COVID-19 pandemic in an Italian region in lockdown with low caseloads (see doi: 10.3390/ijerph17176180). These data could suggest that facing a new and unknown threat was the most stressful factor itself, rather than the number of caseloads. This could be commented when discussing results.

5) Results showed reporting effective institutional safety measures in workplace as well as feeling satisfied at work were significantly associated to lower distress levels. Authors could better discuss this point, for example considering a recent systematic review on healthcare workers facing Coronavirus outbreaks (including COVID-19 pandemic studies) reporting perceived safety of the working environment and a good work organization, as factors which seem to protect healthcare workers to the development of work-related posttraumatic stress, as well as a clear communication of directives and supervisors’ and colleagues’ support (see doi: 10.1016/j.psychres.2020.113312). Similarly to the present results, the same study reported as the fear of infecting others, as well as social isolation and family separation where related to higher distress symptoms.

Reviewer #2: The main aim of this paper was to evaluated distress levels in healthcare workers during the covid-19 pandemic in Jordan. Moreover, the specific aim was to investigate the factors associated with psychological distress in this population in order to carry out psychological interventions to improve medical professionals’ resilience.

Although the topic is interesting, there are some unclear points that must be clarified. The reviewer hopes that the comments below will be helpful to improve the manuscript. The following suggestions are divided into parts.

Introduction

I would suggest you to improve this section by adding other studies about this topic.

Study variables and measures

Referring to the following sentence: “Fear statements were originally measured using a 5-point Likert scale (from “not at all” to “a very great extent”) and then dichotomized for analysis, by considering those who responded “to a considerable extent” and “to a very great extent” as fearful regarding the statement.”, it is not clear the choice to exclude subjects who do not experience fear. Please clarify this point.

Statistical analysis

This section is unsatisfactory. A more detailed description of all analysis carried out is recommended.

Moreover, the authors, have declared the intention to maintain model parsimony. Despite this, I have many concerns about the solidity of the model. Indeed, a high number of variables has been included in the multivariable ordinal logistic regression.

Finally, the latest analysis (the evaluation of the Access to PPE and other perceptions related to PPE use across different professions) deviate from the main objective and risk burdening the study. I suggest to remove them.

Results

The authors point out that the category of nonmedical personnel has been excluded from the analysis. It is therefore not clear why it was included in the final sample. I suggest to take into account the possibility of excluding this category from the final sample.

The authors declared that: “Distress levels correlated consistently and significantly with all fear items and with anxiety and depression scores”.

The association between distress and anxiety and depression scores seems obvious considering that they represent very overlapping constructs. Have the authors taken this into account?

Discussion

I would suggest you to improve this section. The results should be better compared to the literature. There are in fact several other studies about the distress on healthcare workers. Please, see for example Di Tella et al.2020; Castelli et al. 2020.

I suggest you to move the following sentence “Our results suggest that we need to do more with regards to preparing and protecting our healthcare practitioners in anticipation of the realistic possibility of a future surge in Covid-19, given that our finding suggest that our practitioners are already predisposed and have experienced considerable psychological stress.” to the end of the section and to better argue the clinical implications of the study.

Referring to the following sentence “We had originally hypothesized that all pharmacists would experience greater distress…”, it is not clear why the findings are not discussed in relation to the literature (e.g. Basheti et al.)

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Please see attached "Response to Reviewers" document.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Annunziata Romeo, Editor

PONE-D-20-18677R1

The inevitability of Covid-19 related distress among healthcare workers: findings from a low caseload country under lockdown

PLOS ONE

Dear Dr. Hawari

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by April 23 2012 11.59 PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Annunziata Romeo

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Dear authors,

first of all, I consider it honest to report that I participated as a reviewer for the initial evaluation of this manuscript. I think you have correctly addressed all reviewers' concerns and now the manuscript appears clearer.

Notwithstanding this, I encourage you to pay attention to some grammatical/typographical errors (see for example line 291). Moreover, I suggest you to eliminate the following sentence “which eventually did take place during the months of September through November of 2020 in Jordan”(lines 468-469).Finally, since the literature on this subject is getting rich quickly, I suggest you to include this recent review doi.org/10.3389/fpsyg.2020.569935

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Please see attached responses.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Annunziata Romeo, Editor

The inevitability of Covid-19 related distress among healthcare workers: findings from a low caseload country under lockdown

PONE-D-20-18677R2

Dear Dr. Feras Hawari,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Annunziata Romeo

Guest Editor

PLOS ONE

Formally Accepted
Acceptance Letter - Annunziata Romeo, Editor

PONE-D-20-18677R2

The inevitability of Covid-19 related distress among healthcare workers: findings from a low caseload country under lockdown

Dear Dr. Hawari:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Annunziata Romeo

Guest Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .